Skip to main content
. 2007 Feb 13;96(5):692–700. doi: 10.1038/sj.bjc.6603568

Figure 2.

Figure 2

Immunoreactivity of the erythropoietin receptor. (A) Representative immunohistochemistry showing both cytoplasmatic and membrane staining of tumour cells and endothelial cells (arrow). Bar, 25 μm. (B) Comparison of EPO-R immunoreactivity scores in the tumour rim and core of both control and rhEPO-treated animals. Columns, mean; bars, s.e.; *P<0.001 vs the tumour core.